Brijesh K. Sutariya

Mumbai, MH 400098, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Uric Acid Stroke Cerebroprotection Transcended Sex, Age, and Comorbidities in a Multicenter Preclinical Trial.

Uric Acid Stroke Cerebroprotection Transcended Sex, Age, and Comorbidities in a Multicenter Preclinical Trial.

Journal: Stroke

Published: March 17, 2025

Biological and Procedural Predictors of Outcome in the Stroke Preclinical Assessment Network (SPAN) Trial.

Biological and Procedural Predictors of Outcome in the Stroke Preclinical Assessment Network (SPAN) Trial.

Journal: Circulation research

Published: July 22, 2024

A multi-laboratory preclinical trial in rodents to assess treatment candidates for acute ischemic stroke.

A multi-laboratory preclinical trial in rodents to assess treatment candidates for acute ischemic stroke.

Journal: Science translational medicine

Published: September 20, 2023

Targeting Neutrophil α9 Improves Functional Outcomes After Stroke in Mice With Obesity-Induced Hyperglycemia.

Targeting Neutrophil α9 Improves Functional Outcomes After Stroke in Mice With Obesity-Induced Hyperglycemia.

Journal: Stroke

Published: July 14, 2023

Topical SCD-153, a 4-methyl itaconate prodrug, for the treatment of alopecia areata.

Topical SCD-153, a 4-methyl itaconate prodrug, for the treatment of alopecia areata.

Journal: PNAS nexus

Published: July 29, 2022

Polysaccharide conjugates surpass monosaccharide ligands in hepatospecific targeting - Synthesis and comparative in silico and in vitro assessment.

Polysaccharide conjugates surpass monosaccharide ligands in hepatospecific targeting - Synthesis and comparative in silico and in vitro assessment.

Journal: Carbohydrate research

Published: April 13, 2021

Lipid nanoconstructs for superior hepatoprotection: In vitro assessments as predictive tool for in vivo translation.

Lipid nanoconstructs for superior hepatoprotection: In vitro assessments as predictive tool for in vivo translation.

Journal: International journal of pharmaceutics

Published: October 27, 2019

Activation of GLP-1 and Glucagon Receptors Regulates Bile Homeostasis Independent of Thyroid Hormone.

Activation of GLP-1 and Glucagon Receptors Regulates Bile Homeostasis Independent of Thyroid Hormone.

Journal: Current molecular pharmacology

Published: October 01, 2018

Pharmacological inhibition of prolyl hydroxylase protects against inflammation-induced anemia via efficient erythropoiesis and hepcidin downregulation.

Pharmacological inhibition of prolyl hydroxylase protects against inflammation-induced anemia via efficient erythropoiesis and hepcidin downregulation.

Journal: European journal of pharmacology

Published: September 20, 2018

Coagonist of glucagon-like peptide-1 and glucagon receptors ameliorates kidney injury in murine models of obesity and diabetes mellitus.

Coagonist of glucagon-like peptide-1 and glucagon receptors ameliorates kidney injury in murine models of obesity and diabetes mellitus.

Journal: World journal of diabetes

Published: April 23, 2018

Coagonist of glucagon-like peptide-1 and glucagon receptors ameliorates nonalcoholic fatty liver disease.

Coagonist of glucagon-like peptide-1 and glucagon receptors ameliorates nonalcoholic fatty liver disease.

Journal: Canadian journal of physiology and pharmacology

Published: February 07, 2018

Coagonist of GLP-1 and Glucagon Receptor Ameliorates Development of Non-Alcoholic Fatty Liver Disease.

Coagonist of GLP-1 and Glucagon Receptor Ameliorates Development of Non-Alcoholic Fatty Liver Disease.

Journal: Cardiovascular & hematological agents in medicinal chemistry

Published: October 31, 2017

Showing 1-12 of 21

Last Updated: 09/26/2026